These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37230537)

  • 21. Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models.
    Onyshchenko K; Luo R; Rao X; Zhang X; Gaedicke S; Grosu AL; Firat E; Niedermann G
    Theranostics; 2024; 14(6):2573-2588. PubMed ID: 38646638
    [No Abstract]   [Full Text] [Related]  

  • 22. CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer.
    Lim RJ; Salehi-Rad R; Tran LM; Oh MS; Dumitras C; Crosson WP; Li R; Patel TS; Man S; Yean CE; Abascal J; Huang Z; Ong SL; Krysan K; Dubinett SM; Liu B
    Cell Rep Med; 2024 Apr; 5(4):101479. PubMed ID: 38518770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6
    De Wispelaere W; Annibali D; Tuyaerts S; Messiaen J; Antoranz A; Shankar G; Dubroja N; Herreros-Pomares A; Baiden-Amissah REM; Orban MP; Delfini M; Berardi E; Van Brussel T; Schepers R; Philips G; Boeckx B; Baietti MF; Congedo L; HoWangYin KY; Bayon E; Van Rompuy AS; Leucci E; Tabruyn SP; Bosisio F; Mazzone M; Lambrechts D; Amant F
    Clin Transl Med; 2024 May; 14(5):e1655. PubMed ID: 38711203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer.
    Feng M; Wang F; Liu X; Hao T; Zhang N; Deng M; Pan Y; Kong R
    Cancer Biol Med; 2023 May; 20(6):421-37. PubMed ID: 37184030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-5-producing CD4
    Blomberg OS; Spagnuolo L; Garner H; Voorwerk L; Isaeva OI; van Dyk E; Bakker N; Chalabi M; Klaver C; Duijst M; Kersten K; Brüggemann M; Pastoors D; Hau CS; Vrijland K; Raeven EAM; Kaldenbach D; Kos K; Afonina IS; Kaptein P; Hoes L; Theelen WSME; Baas P; Voest EE; Beyaert R; Thommen DS; Wessels LFA; de Visser KE; Kok M
    Cancer Cell; 2023 Jan; 41(1):106-123.e10. PubMed ID: 36525971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
    Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
    J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intralesional administration of VAX014 facilitates in situ immunization and potentiates immune checkpoint blockade in immunologically cold tumors.
    Reil KA; Tsuji S; Molina E; Nelson KL; McGuire KL; Giacalone MJ
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37290924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response.
    Kodumudi KN; Ramamoorthi G; Snyder C; Basu A; Jia Y; Awshah S; Beyer AP; Wiener D; Lam L; Zhang H; Greene MI; Costa RLB; Czerniecki BJ
    Front Immunol; 2019; 10():1939. PubMed ID: 31475002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local TLR4 stimulation augments in situ vaccination induced via local radiation and anti-CTLA-4 checkpoint blockade through induction of CD8 T-cell independent Th1 polarization.
    Jagodinsky JC; Bates AM; Clark PA; Sriramaneni RN; Havighurst TC; Chakravarty I; Nystuen EJ; Kim K; Sondel PM; Jin WJ; Morris ZS
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
    Lal JC; Townsend MG; Mehta AK; Oliwa M; Miller E; Sotayo A; Cheney E; Mittendorf EA; Letai A; Guerriero JL
    Breast Cancer Res; 2021 Aug; 23(1):83. PubMed ID: 34353349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy.
    Su L; Hao Y; Li R; Pan W; Ma X; Weng J; Min Y
    Acta Biomater; 2022 Dec; 154():401-411. PubMed ID: 36241013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice.
    Küçükköse E; Heesters BA; Villaudy J; Verheem A; Cercel M; van Hal S; Boj SF; Borel Rinkes IHM; Punt CJA; Roodhart JML; Laoukili J; Koopman M; Spits H; Kranenburg O
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma.
    Lelliott EJ; Mangiola S; Ramsbottom KM; Zethoven M; Lim L; Lau PKH; Oliver AJ; Martelotto LG; Kirby L; Martin C; Patel RP; Slater A; Cullinane C; Papenfuss AT; Haynes NM; McArthur GA; Oliaro J; Sheppard KE
    Cancer Immunol Res; 2021 Feb; 9(2):136-146. PubMed ID: 33303574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of CD8
    Teh JLF; Erkes DA; Cheng PF; Tiago M; Wilski NA; Field CO; Chervoneva I; Levesque MP; Xu X; Dummer R; Aplin AE
    Cancer Immunol Res; 2020 Sep; 8(9):1114-1121. PubMed ID: 32661093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor beta signaling in CD8
    Yuan B; Clark CA; Wu B; Yang J; Drerup JM; Li T; Jin VX; Hu Y; Curiel TJ; Li R
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors.
    Espinosa-Carrasco G; Chiu E; Scrivo A; Zumbo P; Dave A; Betel D; Kang SW; Jang HJ; Hellmann MD; Burt BM; Lee HS; Schietinger A
    Cancer Cell; 2024 Jul; 42(7):1202-1216.e8. PubMed ID: 38906155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8
    Semmrich M; Marchand JB; Fend L; Rehn M; Remy C; Holmkvist P; Silvestre N; Svensson C; Kleinpeter P; Deforges J; Junghus F; Cleary KL; Bodén M; Mårtensson L; Foloppe J; Teige I; Quéméneur E; Frendéus B
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35058324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy.
    Lauret Marie Joseph E; Kirilovsky A; Lecoester B; El Sissy C; Boullerot L; Rangan L; Marguier A; Tochet F; Dosset M; Boustani J; Ravel P; Boidot R; Spehner L; Haicheur-Adjouri N; Marliot F; Pallandre JR; Bonnefoy F; Scripcariu V; Van den Eynde M; Cornillot E; Mirjolet C; Pages F; Adotevi O
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34230108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.